Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Pathological Complete Response|Neoadjuvant Chemotherapy
Interventions: DRUG: Epirubicin|DRUG: Fluorouracil|DRUG: Docetaxel|DRUG: Cyclophosphamide
Sponsor: Zhiyong Yu